Clinical Trials Logo

Clinical Trial Summary

Respiratory virus infections cause a majority of asthma exacerbations in the fall to spring months. Current diagnostic platforms for respiratory viruses have limitations including cost, availability, and invasiveness. The use of noninvasive breath collection to analyze breath metabolites may be used to differentiate virus-infected asthmatics from other causes of acute asthma exacerbations.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03089970
Study type Observational
Source University of California, Davis
Contact
Status Completed
Phase
Start date February 1, 2017
Completion date September 1, 2020